Malta - inglés - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - benzylpenicillin sodium - powder for injection - benzylpenicillin sodium 600 milligram(s) - antibacterials for systemic use

Kenia - inglés - Pharmacy and Poisons Board

benzylpenicillin sodium - powder for injection - 1 mega / vial - benzylpenicillin

Kenia - inglés - Pharmacy and Poisons Board

benzylpenicillin sodium - powder for injection - 5 mega / vial - benzylpenicillin

Australia - inglés - APVMA (Australian Pesticides and Veterinary Medicines Authority)

jurox pty limited - benzylpenicillin sodium - unknown - benzylpenicillin sodium antibiotic-penicillin active 0.0 - active constituent

Filipinas - inglés - FDA (Food And Drug Administration)

health saver pharma inc - benzylpenicillin (as sodium) - powder for injection im/iv - 1,000,000 iu (600mg)

Filipinas - inglés - FDA (Food And Drug Administration)

medical generics mktg co., - benzylpenicillin (as sodium) - powder for injection im/iv - 1,000,000 iu (600mg)

Australia - inglés - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - benzylpenicillin procaine - unknown - benzylpenicillin procaine antibiotic-penicillin active 0.0 - active constituent

Australia - inglés - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - procaine benzylpenicillin, quantity: 1.5 g - injection, suspension - excipient ingredients: sodium citrate dihydrate; water for injections; polysorbate 80 - indications as at 18 february 2002: treatment of moderately severe infections due to penicillin sensitive organisms. therapy should be guided by bacteriological studies, including sensitivity tests and also by clinical response. infections which usually respond to adequate dosage are: group a streptococcal infections including upper respiratory tract infections, skin and skin structure infections and scarlet fever; pneumococcal infections of the respiratory tract; susceptible staphylococcal infections, most gonococcal infections, syphilis, fusospirochaetosis (vincent's gingivitis and pharyngitis). cilicaine syringe 1.5 must be administered by the intramuscular route only (see section 4.2 dose and method of administration).

Australia - inglés - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - benzathine benzylpenicillin tetrahydrate, quantity: 1200000 usp unit - injection, suspension - excipient ingredients: water for injections; sodium citrate; carmellose sodium; povidone; propyl hydroxybenzoate; methyl hydroxybenzoate; lecithin - intramuscular benzathine penicillin is indicated in the treatment of infections due to penicillin-sensitive micro-organisms that are susceptible to the low and very prolonged serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. the following infections will usually respond to adequate dosage of intramuscular benzathine penicillin: streptococcal infections (group a - without bacteraemia). mild-to-moderate infections of the upper respiratory tract (e.g. pharyngitis). venereal infections - syphilis, yaws, bejel and pinta. medical conditions in which benzathine penicillin therapy is indicated as prophylaxis: rheumatic fever and/or chorea - prophylaxis with benzathine penicillin has proven effective in preventing recurrence of these conditions. it has also been used as a follow-up prophylactic therapy for preventing rheumatic heart disease and acute glomerulonephritis.

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - benzylpenicillin sodium - eye drops - 1.5mg/1ml